Multi-Institutional Study of Post-Transplantation Cyclophosphamide as Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning
Journal of Clinical Oncology - United States
doi 10.1200/jco.2013.54.0625
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2014
Authors
Publisher
American Society of Clinical Oncology (ASCO)